Tracing the international arrivals of SARS-CoV-2 Omicron variants after Aotearoa New Zealand reopened its borderArticle Published on 2022-10-292022-11-16 Journal: Nature Communications [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] Community explained genomes Genomic surveillance growth advantage Infection International lineages New omicron onward transmission Outbreaks provide SARS-CoV-2 SARS-CoV-2 lineage significant level tracing Transmission Travel triggered variant [DOI] 10.1038/s41467-022-34186-9 PMC 바로가기
Decreased Sensitivity of Rapid Antigen Test Is Associated with a Lower Viral Load of Omicron than Delta SARS-CoV-2 VariantArticle Published on 2022-10-262022-11-15 Journal: Microbiology Spectrum [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] Abbott Affect Analysis analyzed Antigen carried Characteristics Clinical characteristics clinical information collected COVID-19 Decreased Delta delta variant Diagnosis diagnostic diagnostics Effectiveness Epidemic evaluate explained Factor Health care worker individual Infection International less load Lower marker median Mutation nasopharyngeal specimen National omicron PanBio performed positive question Rapid Rapid diagnostic test RDT RDTs reduced repeated replicate RT-PCR SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant screening strategy sensitivity shown significantly higher significantly lower specific mutation Test the disease Variability variant variants variants of concern Viral load Viral load. viral replication Virological VoC [DOI] 10.1128/spectrum.01922-22 PMC 바로가기
Environmental Impacts on COVID-19: Mechanisms of Increased SusceptibilityArticle Published on 2022-10-212022-11-16 Journal: Annals of Global Health [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome addition age Air pollution antioxidant benefit boost caused changes in children clinical symptom combating coronavirus COVID COVID 19 COVID-19 COVID-19 susceptibility death described disease Diseases Environment Epidemiology exposure to free radical Health host immunity host susceptibility Impact Increased induce Inflammatory cytokine storm inhibit Initially International involved knowledge less mechanism morbidity and mortality outcomes oxidative stress pediatric Preliminary data reduce respiratory tract respiratory viral infections respiratory viral infections. SARS-CoV-2 SARS-COV-2 infection severe COVID-19 severe disease severity severity of COVID-19 shown susceptibility susceptible the disease Vaccine variant viral genome viral infections viral pathogenicity while [DOI] 10.5334/aogh.3907 PMC 바로가기
The SARS-CoV-2 Infection Among Students in the University of Porto: A Cross-Sectional StudyArticle Published on 2022-10-202022-11-15 Journal: International Journal of Public Health [Category] COVID19(2023년), SARS, 진단, [키워드] 95% CI age antibodies applied Bayesian inference Contact Evidence groups IgG IgG antibody IgM Immunoglobulin immunological Infection International interval Local male Molecular diagnosis molecular test Older point of care Porto Prevalence quarantine questionnaire reactive reported risk SARS-CoV-2 SARS-CoV-2 specific antibody Seroepidemiology Seroprevalence significantly higher student Symptoms university university students. was performed [DOI] 10.3389/ijph.2022.1604548 PMC 바로가기
News from around the RNA world: new avenues in RNA biology, biotechnology and therapeutics from the 2022 SIBBM meetingArticle Published on 2022-10-152022-11-16 Journal: Biology open [Category] 유전자 메커니즘, [키워드] Biology Biophysics cell differentiation cellular Circular circular RNAs Community COVID19 disease DNA Dogma highlighting information International involved Italian modulating Molecular biology National New Non-coding RNAs, microRNAs Pandemics Protein provided RNA RNA therapies. RNAs Rome Society Stress Therapies therapy transcript translational [DOI] 10.1242/bio.059597 PMC 바로가기
Application of a Decision Tree Model to Predict the Outcome of Non-Intensive Inpatients Hospitalized for COVID-19Article Published on 2022-10-112022-11-15 Journal: International Journal of Environmental Research an [Category] 진단, [키워드] Accuracy application applied approach Blood clinical aspect clinician coronavirus disease COVID-19 decision Disease progression evaluate haematochemical parameters Health help Immunoglobulin information Inpatient intensive care units International machine learning Model normalized outcome outcomes parameter Patient patients with COVID-19 physician prediction predictor Prognostic markers prognostic markers. Prospective Study Prothrombin time repeated Research Retrospective study risk of death sensitivity specificity threshold to define tree worsening [DOI] 10.3390/ijerph192013016 PMC 바로가기
Humoral immunogenicity of COVID-19 vaccines in patients with inflammatory rheumatic diseases under treatment with Rituximab: a case-control study (COVID-19VacRTX)Article Published on 2022-10-062022-11-15 Journal: Rheumatology (Oxford, England) [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] Ad26.COV2.S ANCA-associated vasculitis anti-CD20 antibody antibody level Antibody titre approved AZD1222 B cell B-cell B-cells blood sample case-control study CD19+ COVID-19 COVID-19 vaccine dose ELISA evaluated examined Factor first vaccination Frame help humoral humoral immune response immunogenicity Immunoglobulin Improved increased risk Inflammatory International mAb Moderna outcomes parameter Patient quantified RA reduced regimen rheumatic disease rituximab RNA-1273 RTX SARS-CoV-2 severe COVID-19 synchronization the patient therapeutic therapy treated Treatment Univariate analysis vaccination vaccination. Vaccine [DOI] 10.1093/rheumatology/keac036 PMC 바로가기
Detecting and mitigating simultaneous waves of COVID-19 infectionsArticle Published on 2022-10-062022-11-15 Journal: Scientific Reports [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] Affect Analysis B.1.617.2 Can can be used catch caused country COVID-19 COVID-19 infection Data analysis Delta detect diffusion disease early stage Epidemic epidemiological geographical region growth healthcare Healthcare system Hypothesis identify India Infection International recommendation resource respond reveal second wave Shock Spread spread of COVID-19 Stage super-spreader event super-spreader events Support the disease the epidemic the SARS-CoV-2 virus the United State Travel variant [DOI] 10.1038/s41598-022-20224-5 PMC 바로가기
An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patientsArticle Published on 2022-10-052022-11-16 Journal: eLife [Category] COVID19(2023년), SARS, 변종, [키워드] adjusted analysis Analysis Appendix approach assumption available data Calabria carrier caused changes in characterisation clinical Clinical outcome Clinical research clinical study collected Commonwealth confidence interval confounders COVID-19 dataset DAVID development Donor emergence Epidemiology European European Commission fatality Foreign foundation Frequency funding global health Google.org group heterogeneity Horizon hospital hospitalised hospitalised patient Imperial College London include infecting Infection Infectious disease International IRCCS ISARIC Italian Joshua less Logistic regression lower mortality Medical Research Council Medicine Melinda Gate Microbiology Ministry of Health network NIHR NIHR HPRU Odds ratio office omicron opportunity outcome Oxford Patient PHE protection Public Health England Rapid relative frequencies reported symptom Research respiratory response responsible Rockefeller Foundation SARS-CoV-2 variant School Semple sensitivity analysis Sriniva study population subset Support supported Symptoms union unit University of Liverpool University of Oxford variant variants viral genomic information viruses viruses. with COVID-19 [DOI] 10.7554/eLife.80556 PMC 바로가기
Vaccines, Variants, and Vigilance: Strengthening the Coronavirus Disease 2019 (COVID-19) Public Health Response Through Partnerships and CollaborationsArticle Published on 2022-10-032022-11-16 Journal: Clinical Infectious Diseases: An Official Publicat [Category] COVID19(2023년), SARS, 변종, [키워드] acute respiratory syndrome caused CDC center collaboration Collaborative effort Control coronavirus coronavirus disease COVID-19 disease severity Government Health IMPROVE Infection International knowledge Local pandemic partnership prevention Public public health reduce response SARS-CoV-2 The United States Transmission Vaccines Vaccines. variants [DOI] 10.1093/cid/ciac522 PMC 바로가기